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ϩ and fluid changes resulting from this therapeutic modality on the [Na ϩ ]pw. In this article, we derive a new formula for predicting alterations in the plasma Na ϩ concentration ([Na ϩ ]p) in patients on peritoneal dialysis, taking into consideration the empirical relationship between the [Na ϩ ]pw and Nae, Ke, and TBW (Eq. 1) as well as changes in mass balance of Na ϩ ϩ K ϩ and H2O. potassium IN PERITONEAL DIALYSIS (PD), ALTERATIONS in the total exchangeable sodium (Na e ), total exchangeable potassium (K e ), and total body water (TBW) occur as a result of diffusive transport, convective transport, and ultrafiltration (4). The removal (or addition) of Na ϩ and K ϩ from the body fluid compartments results from passive diffusion down a concentration gradient from the plasma into the dialysate or vice versa. The frictional forces between water and solutes termed "solvent drag" also result in the convective transport of Na ϩ and K ϩ across the peritoneal membrane. In addition to solute removal, H 2 O is also removed during PD by the process of ultrafiltration, thereby leading to a change in TBW. Moreover, other nondialytic causes of changes in the input or output of Na ϩ , K ϩ , and H 2 O that contribute to an alteration in the Na e , K e , and TBW in these patients need to be considered. By accounting for changes in the mass balance of Na 
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Rearranging Eq. 2A
where
In the setting of hyperglycemia, Eq. 8 must be modified to account for the dilutional effect of blood glucose on the [Na ϩ ] p . We have previously demonstrated that the y-intercept in the Edelman equation is not constant and will vary predictably with the plasma glucose concentration (17, (23) (24) (25) . Moreover, we have previously shown (17, (23) (24) (25) 
Therefore, to account for the fact that there is an expected decrease of 1.6 meq/l in the [Na ϩ ] p for each 100-mg/dl increment in the plasma glucose concentration (16) , Eq. 8 must be generalized as follows: Various analyses of the pathogenesis and treatment of the dysnatremias have failed to consider the quantitative and physiological significance of the slope and y-intercept in Edelman's equation (1, 3, 7, 14, 20, (27) (28) (29) 31) . Indeed, these analyses have failed to consider the physiological significance of the slope (1.11) and y-intercept (Ϫ25.6) by implicitly assuming that the [Na ϩ ] p is exactly equal to the ratio (Na e ϩ K e )/TBW (1, 3, 7, 14, 20, (27) (28) (29) 31) . By assuming that the [Na ϩ ] p is exactly equal to the ratio (Na e ϩ K e )/TBW, these analyses also erroneously equate the patient's Na e ϩ K e to the product of the [Na ϩ ] p and TBW. Recently, new insights into the pathophysiology and treatment of the dysnatremias have highlighted the quantitative and physiological significance of the slope and y-intercept in the Edelman equation (17, (21) (22) (23) (24) (25) (26) . We have demonstrated that the empirically determined slope of 1.11 in the Edelman equation (11) can be theoretically predicted by considering the combined effect of the osmotic coefficient of Na ϩ salts at physiological concentrations and Gibbs-Donnan equilibrium (24, 25) . The ionic interactions between Na ϩ and its associated anions (as reflected by the osmotic coefficient of Na ϩ salts) have a modulating effect on the [Na ϩ ] pw . Moreover, our mathematical analysis demonstrated that Gibbs-Donnan equilibrium has an incremental effect on the [Na ϩ ] pw . Because the presence of negatively charged, impermeant proteins in the plasma space alters the distribution of Na ϩ and Cl Ϫ ions between the plasma and interstitial fluid to preserve electroneutrality, the Gibbs-Donnan effect raises the [Na ϩ ] pw at any given quantity of (Na e ϩ K e )/TBW (24, 25) .
There are several determinants of the y-intercept in the Edelman equation which independently alter the [Na ϩ ] pw : osmotically inactive exchangeable Na ϩ and K ϩ , plasma water [K ϩ ], and osmotically active non-Na ϩ and non-K ϩ osmoles (21, 23-26 ). There is convincing evidence for the existence of an osmotically inactive Na ϩ and K ϩ reservoir (5, 9 -11, 15, 30, 32, 33). These osmotically inactive Na e and K e are ineffective osmoles, and they do not contribute to the distribution of water between the extracellular and intracellular compartments. Because the Na e and K e in the Edelman equation include osmotically active as well as osmotically inactive components, the inactivation of Na e and K e is, therefore, accounted for quantitatively by the osmotically inactive Na e and K e term in the y-intercept (23) (24) (25) . Moreover, the other components of the y-intercept reflect the fact that non-Na ϩ osmoles are also involved in the distribution of water between the body fluid compartments (23) (24) (25) . Therefore, the components of the yintercept reflect the role of osmotic equilibrium in the modulation of the [Na ϩ ] pw . Taking into consideration the quantitative and physiological significance of the slope and y-intercept in the Edelman equation, we have demonstrated that the initial Na e ϩ K e can be determined as follows (17, 21, (23) (24) (25) :
Accordingly, Eq. 2C is incorporated in the derivation of Eq. 8. In addition, by utilizing the complete Edelman equation in its derivation, Eq. 8 takes into consideration the modulating effect of Gibbs-Donnan and osmotic equilibrium on the [Na
As the slope and y-intercept in the Edelman equation have several determinants, alterations in these parameters induced by PD are expected to result in changes in the slope and y-intercept in Eq. 1. Since the slope of Eq. 1 is determined by the combined effect of the osmotic coefficient of Na ϩ salts at physiological concentrations and Gibbs-Donnan equilibrium (24, 25) , hypoalbuminemia resulting from dialysate protein loss and malnutrition would be expected to change the slope of Eq. 1 by altering Gibbs-Donnan equilibrium. The magnitude of change in the slope of Eq. 1 induced by hypoalbuminemia is unknown at the present time and is the subject of current investigation. Similarly, alterations in the parameters comprising the y-intercept would lead to a change in its magnitude. As patients undergoing PD are exposed to a continuous infusion of glucose via their peritoneal cavity, poor glycemic control in diabetic patients on PD would result in an alteration in the magnitude of the y-intercept. Indeed, we have previously demonstrated that the y-intercept is not constant in hyperglycemia-induced dilutional hyponatremia resulting from the translocation of water and will vary directly with the plasma glucose concentration (17, (23) (24) (25) . Consequently, a modified y-intercept must be utilized in the setting of hyperglycemiainduced hyponatremia because hyperglycemia will lead to changes in several components of the y-intercept (17, (23) (24) (25) .
Poor glycemic control is common in diabetic patients on PD due to dialysate glucose absorption (19) . In addition to the alterations in Na e , K e , and TBW, changes in the [Na ϩ ] p in these patients also reflect the dilutional effect of plasma glucose on the [Na ϩ ] p . It is well known that there is an expected decrease of 1.6 meq/l in the [Na ϩ ] p for each 100-mg/dl increment in the plasma glucose concentration resulting from the osmotic shift of water between the intracellular fluid compartment and the extracellular fluid compartment (16) . This dilutional effect of plasma glucose on the [Na ϩ ] p is reflected by a change in the magnitude of the y-intercept. Indeed, we have demonstrated that the magnitude of the y-intercept will vary directly with the plasma glucose concentration as a result of changes in several components of the y-intercept (17, (23) (24) (25) . Our analysis also indicated that the following formula can be used to predict the effect of changes in the Na e , K e , and TBW as well as the dilutional effect of hyperglycemia on the [Na 
